Patent · US Active

Compositions and methods for the treatment of cancer

US8513292B2 · kind B2 · utility

0Cited by
19References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 19, 2008
Grant dateAug 20, 2013
Priority date
Expiry dateJan 27, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to pyrrolidine-2,5-dione compounds, and methods of preparation of these compounds. The present invention also relates to pharmaceutical compositions comprising pyrrolidine-2,5-dione compounds. The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a compound or pyrrolidine-2,5-dione compound of the present invention. (Ia) (Ib) (IIa) (IIIb) Where U is independently selected from: (I) or (II)where U is independently selected from:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.